SAFETY OF BIOLOGICS FOR THE TREATMENT OF AUTOIMMUNE DISEASES: A CROSS-SECTIONAL STUDY FROM SAUDI ARABIA

Journal Title: World Journal of Pharmaceutical Research - Year 2019, Vol 8, Issue 9

Abstract

Purpose: This cross-sectional study explored the safety of biological therapies, association between patient characteristics, adverse events (AEs) and biological therapy among treated patients and assess patient-perceived treatment effectiveness of the biologics in autoimmune diseases (AD) patients in Riyadh, Saudi Arabia. Methods: AD patients (ulcerative colitis [UC] and Crohn’s disease [CD], rheumatoid arthritis [RA], and psoriasis [PsO]) who received adalimumab, infliximab, rituximab, or etanercept were analyzed. Results: Of the 115 biologically-treated AD patients (CD=80; RA=18; UC=16; PsO=1), 88.7% received infliximab. Over 95% of the patients experienced at least one AE, with higher prevalence in infliximab cohort than other cohorts. Most common AEs were weight gain (20%–57.1%), hair loss (20%–42.8%), and stomach pain (14.3%–22.6%). Infections occurred in 16.5% of patients; acute nose, throat, and sinus infections and urinary tract infections were the most common infections. There was a lack of association between the variables, biological therapy, and AEs among the treated AD patients. Majority of the treated-patients (89%) reported improvement after treatment with biological therapy; 92% expressed their willingness to continue with the prescribed biological therapy. Conclusions: This study provides valuable data on the safety and patient perceived treatment effectiveness of biologics used for the treatment of various AD.

Authors and Affiliations

Dr. Lamya Al Naim

Keywords

Related Articles

AN OUTLOOK TO FORM FILL SEAL TECHNOLOGY

Form fill seal (FFS) technology is an automated computer operated technology, to prepare sterile products. Form-fill-seal technology is subject to constant development, a manufacturer requires modern and reliable packagi...

THE BIOLOGICAL EFFECT OF B-SITOSTEROL ON HEPATOMA CELL HEPG2 TRANSFECTED WITH HBX GENE

Hepatitis B virus (HBV) infection is endemic disease in many areas around the world and is considered as one of the risk factor for hepatocellular carcinoma .The latter is the fifth leading cause of death and rapidly inc...

THE ROLE OF ADIPONECTINE HORMONE IN OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME ON OOCYTE AND EMBRYO QUALITY AFTER INTRACYTOPLASMIC SPERM INJECTION PROTOCOL

Both Polycystic ovary syndrome and obesity are associated with specific reproduction health complications, including lower oocyte quality and pregnancy rates in assisted conception cycles which may be due to the endocrin...

AYURVEDIC APPROACH TOWARDS WOMEN SPECIFIC GERIATRIC DISEASES

Life is a time bound phenomenon. The man is born, grows to adulthood, passes to senility and ultimately dies. Still a long healthy life is the most cherished desire of man. The process of aging is a self induced continuo...

CLINICAL EFFECTS OF TRIPHALA GUGGULU ON DIABETIC MACULAR EDEMA

Diabetic macular edema (DME) is the largest cause of visual acuity loss in Diabetes. It mainly affects the central vision from early stages of retinopathy, and it is the most common sight-threatening complication of diab...

Download PDF file
  • EP ID EP672892
  • DOI -
  • Views 164
  • Downloads 0

How To Cite

Dr. Lamya Al Naim (2019). SAFETY OF BIOLOGICS FOR THE TREATMENT OF AUTOIMMUNE DISEASES: A CROSS-SECTIONAL STUDY FROM SAUDI ARABIA. World Journal of Pharmaceutical Research, 8(9), 98-109. https://europub.co.uk/articles/-A-672892